Gamma-delta T cell product
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gamma-delta T cell product, covering 2025-03-05 to 2025-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases [Phase 1]